61035-87-8

Basic information

• Product Name: 4-ISOPROPYLPHENETHYLAMINE HYDROCHLORIDE
• Synonyms: 4-(1-methylethyl)benzeneethanaminehydrochloride;4-(1-methylethyl)-benzeneethanaminhydrochloride;4-Isopropylphenethylamine hydrochloride 97%
• CAS NO: 61035-87-8
• Molecular Formula: C₁₁H₁₇N*ClH
• Molecular Weight: 199.72032
• Product Categories: Amine Salts;Building Blocks;Chemical Synthesis;Nitrogen Compounds;Organic Building Blocks
• Mol File: 61035-87-8.mol
• Article Data: 5

Chemical Properties

• Melting Point: 167-172 °C
• Boiling Point: 247.7°C at 760 mmHg
• Flash Point: 108.6°C
• Appearance: /
• Vapor Pressure: 0.0253mmHg at 25°C
• CAS DataBase Reference: 4-ISOPROPYLPHENETHYLAMINE HYDROCHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-ISOPROPYLPHENETHYLAMINE HYDROCHLORIDE(61035-87-8)
• EPA Substance Registry System: 4-ISOPROPYLPHENETHYLAMINE HYDROCHLORIDE(61035-87-8)

Safety Data

• Hazard Codes: C
• Statements: 34
• Safety Statements: 26-36/37/39-45
• RIDADR: UN 3263 8/PG 3
• WGK Germany: 3
• RTECS: DA0306900
• Hazardous Substances Data: 61035-87-8(Hazardous Substances Data)

Usage

General Description

4-Isopropylphenethylamine hydrochloride, also known as 4-IPA, is a chemical compound that belongs to the family of phenethylamines. It is an organic compound with the molecular formula C11H18ClN, and it is commonly used as a precursor in the synthesis of pharmaceutical drugs and other organic compounds. 4-Isopropylphenethylamine hydrochloride is often used in the production of medications for various medical conditions, and it is also used in research and development in the pharmaceutical industry. It is a white crystalline powder that is soluble in water and other organic solvents, and it is regulated and controlled due to its potential for misuse or abuse.

InChI:InChI=1/C11H17N.ClH/c1-9(2)11-5-3-10(4-6-11)7-8-12;/h3-6,9H,7-8,12H2,1-2H3;1H

Upstream product

• 4395-87-3 (4-isopropylphenyl)acetonitrile 

Downstream Products

• 1144524-52-6 methyl 3-[3-((2-[4-(1-methylethyl)phenyl]ethyl)amino)-3-oxopropyl]-1-phenyl-1H-indole-5-carboxylate 

Relevant articles and documents

HUMAN ETS-RELATED GENE (ERG) COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE

This invention provides compound having a structure of Formula (I): (I) Uses of such compounds for treatment of ERG, FLI1, ETV4, or ETV1 -mediated indications, including cancer. Also provided are pharmaceutical composition and methods of treating ERG, FLI1, ETV4, or ETV1-mediated indications, including cancer. The cancer may be selected from the group consisting of: prostate cancer, Ewing's sarcoma, breast cancer or pancreatic cancer.

PREVENTIVE OR THERAPEUTIC AGENT FOR KIDNEY DISEASE

The present invention relates to an agent for the prevention or treatment of a renal disease comprising as an active ingredient a 5-amidino-2-hydroxybenzenesulfonamide derivative represented by the general formula: wherein R1 is a hydrogen atom or an optionally substituted alkyl group; R2 is a dialkylamino group, an alkyl group, a cycloalkyl group, an optionally substituted aryl group etc.; T is an oxygen atom, a sulfur atom etc.; Q is a hydrogen atom or an optionally substituted alkyl group; and Z is a hydrogen atom, a hydroxy group etc., or a pharmaceutically acceptable salt thereof which has an inhibitory effect on mesangial cell proliferation and a decreasing effect on protein excretion in urine, and are useful for preventing or treating of various renal diseases such as IgA nephropathy, diabetic nephropathy, nephritic syndrome and the like.

5-AMIDINO-2-HYDROXYBENZENESULFONAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES FOR THEIR PREPARATION

The present invention relates to a 5-amidino-2-hydroxybenzenesulfonamide derivative represented by the general formula: wherein R1 is a hydrogen atom or an optionally substituted lower alkyl group; R2 is a di(lower alkyl)amino group,